UK markets open in 6 hours 26 minutes

Akebia Therapeutics, Inc. (AKBA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7100+0.1300 (+8.23%)
At close: 04:00PM EST
1.7300 +0.02 (+1.17%)
After hours: 08:00PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts3333
Avg. Estimate-0.04-0.09-0.32-0.28
Low estimate-0.06-0.1-0.34-0.32
High estimate-0.03-0.08-0.3-0.25
Year ago EPS-0.04-0.14-0.51-0.32
Revenue estimateCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
No. of analysts3333
Avg. Estimate55.39M41.61M193.88M192.65M
Low estimate54.9M38.8M193.39M188.11M
High estimate56.31M43.1M194.74M194.94M
Year ago sales55.18M40.13M292.6M193.88M
Sales growth (year/est)0.40%3.70%-33.70%-0.60%
Earnings history30/12/202230/03/202329/06/202329/09/2023
Est. EPS-0.19-0.15-0.02-0.08
Actual EPS-0.04-0.14-0.06-0.08
Difference0.150.01-0.040
Surprise %78.90%6.70%-200.00%0.00%
EPS trendCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Current estimate-0.04-0.09-0.32-0.28
7 days ago-0.04-0.09-0.32-0.28
30 days ago-0.04-0.09-0.32-0.28
60 days ago-0.04-0.09-0.32-0.29
90 days ago-0.04-0.09-0.32-0.29
EPS revisionsCurrent qtr. (Dec 2023)Next qtr. (Mar 2024)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAKBAIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.35.70%N/AN/AN/A
Current year37.30%N/AN/AN/A
Next year12.50%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A